Two, not three, is company for HAART

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1569, 2007-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Three might be company for antiplatelet therapy after stenting

Inpharma, Vol. 1, Iss. 1520, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Study suggests that limitations of HAART can be explained by genetic differences at two human loci

Future Virology, Vol. 3, Iss. 3, 2008-05 ,pp. : 203-205

Future Medicine

Access to resources Recommend Favorite

Three-state and two-state models

By Strange P.G.

Trends in Pharmacological Sciences, Vol. 19, Iss. 3, 1998-03 ,pp. : 85-86

Elsevier

Access to resources Recommend Favorite

HAART to HAART: Current and Future Pharmacotherapies For HIV

By Adis International Limited

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 6, 2004-11 ,pp. : 17-21

Adis International

Access to resources Recommend Favorite

Immunisation facilitates HAART interruption

Inpharma, Vol. 1, Iss. 1531, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite